Silicon Valley’s psychedelic wonder drug is almost here

MIND MEDICINE MINDMED INC. [MMEDF: OTCQB]

3.34 -0.12 (-3.49%) 02/26/2021 Delayed 15 minutes

Open	$3.54	Daily Range	$3.15-$3.54
Prev. Close	$3.44	52 Week Range	$0.0833-$5.07
Volume	2,457,597

Quote Data Realtime

Inside Quote
Bid	Ask	Last Inside Change
$3.31 x 525 shares	$3.32 x 9212 shares	02/26 4:23 PM EST

Level II Quote Montage

BID

ASK

MMID	Bid Price	Bid Size	Date/Time
CDEL	3.31	525	15:59
GTSM	3.30	2616	15:59
NITE	3.30	1550	15:59
ETRF	3.30	847	15:59
INTL	3.30	300	15:59
VALX	3.29	5800	15:59
JANE	3.29	5000	15:59
OTCX	3.29	9200	15:59
CSTI	3.28	100	15:59
VNDM	2.99	6000	09:30
PAUL	2.88	100	02/23
MAXM	2.71	8900	09:30
LAFC	2.52	100	12/22
VERT	1.97	100	01/28
PUMA	1.42	100	08:10
BGCE	1.00	100	02/23
WABR	1.00	100	02/01
MCAP	0.80	1000	15:59
cCANT	2.52	100	02/23

MMID	Ask Price	Ask Size	Date/Time
NITE	3.32	8253	15:59
CSTI	3.32	959	15:59
OTCX	3.34	1500	15:59
INTL	3.34	800	15:59
ETRF	3.35	100	15:59
VALX	3.36	2900	15:59
JANE	3.38	5000	15:59
CDEL	3.38	1000	15:59
GTSM	3.40	800	15:21
MAXM	3.50	100	09:30
VNDM	3.50	100	11:48
PAUL	4.50	100	02/17
VERT	5.00	100	01/22
PUMA	5.44	100	08:10
LAFC	5.45	100	12/14
MCAP	5.86	100	15:59
BGCE	5.98	100	02/23
WABR	100.00	100	02/12
cCANT	6.00	100	01/21

The quotes displayed here are published by market makers on the OTC Markets Group Inc. electronic inter-dealer quotation and trading system for OTC securities. Please see Terms of Service and Risk Warning for more information.

MMID - Market maker quotation published in OTC Link that meets the Inside market | MMID - Market maker quotation published in OTC Link | cMMID - Closed quote | Unpriced - Unpriced quote in OTC Link | MMIDu - Unsolicited market maker quotation published in OTC Link

A new startup called MindMed could have the key to providing the upsides of psychedelic drugs for both focus and addiction treatment—while cutting out the downsides of tripping.

read the full Fast Company article

https://www.fastcompany.com/90436824/silicon-valleys-psychedelic-wonder-drug-is-almost-here

Silicon Valley’s psychedelic wonder drug is almost here

Browse more articles